Member Info for JustHereForHemo

It's frustrating but when the share price is dropping despite there being more buys than sells and the MM s won't give a live quote for more than 1 share for hours at a time and then you see large buy orders after hours you should be skeptical. Investors want the shares, they want them cheap and they want to make it look like price is falling so PIs panic and sell.
If price was rising PIs would be piling in and it would be impossible for IIs to get big orders filled on the cheap.
Market Makers are not your friends.
Big investors are not your friends.
Trust your research and if you think it's a good investment then ignore the share price.

#InVladWeTrust

You know fine rightly that the placing was not 5p, considering that your a day trader who intentionally tries to drop the sp to buy in cheaper yes i consider it a lie. I don't like you and back on the filter you go makes for a much better weekend, but for everyone else here you go https://www.lse.co.uk/rns/HEMO/conditional-placing-to-raise-2500000-khevibsl6ax3fst.html save listening to her

Honestly, either way you look at it its no bad thing EITER:
A, It is a typo and there is one global co who is Eli Lilly and we are so interwoven with them its hard to imagine anything but a take over eventually.
OR
Hemogenyx a 30m TEENY WEENY mCap company is working with MORE Global Pharmas beyond J&J and Eli Lilly(24 BILLION Revenue PER YEAR).

Whatever way you want to look at it we are hitting well above our weight.
B,

Raised this issue with someone from Peterhouse earlier, going to look into it. Suspect its a copy and paste error and nothing significant.

Some definate funny business by the MMs today. But its blue, ill take that over a red day anytime. I HOPE that 1 trade was a joke, we DO NOT WANT a Friday afternoon RNS... Keep it till monday Vlad!!!

Not sure if you missed it?
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
Revenue: 24.56 billion USD (2018)
Number of employees: 33,815 (June 2019)

^ This is Global Co

bdcarr I am the same, I have no spreadsheet, I dont presume to think I am smarter than traders who do this day in day out. I buy shares, top up when I can and wait. Yes I see other people selling in one place, timing their entry, getting a 20% here or there, but I also see people getting spiked and losing just as much.
IMO Hemo will come very good for me very soon and I will be very well off because of it. I have patience and I am not worried about my investment. Might happen in a week might happen in a month or so.
When I see the SP drop I like to see whats going on and time and time again its always the same (bar a 100k sell 2 days ago which was an outlier) MMs drop the price even though there seems to be more buying than selling, everything looks like a sell even though half are buys, then few hrs or a day or 2 later there is a big buy.
As time goes on the investors with smaller holdings who may have a big portfolio seem to be selling hemo, you will see more an more sells of< 50k shares. But then there are more bigger buys in blocks of 50/100/200k sizes.
Investors who have alot more time/money/expertise are buying and holding Hemo so I think there is more chance of Donald Trump joining MENSA than me losing my investment here.

Unfortunatly that is not an option for me, self employed and cant take any more dividends for 3 months... That said if share price stays low for another week or so I am moving my pension to a SIPP so I will have more freedom then :-)
Good luck :-) For a long time my plan was to hold until £1.80, I have to say I have scrapped that plan, ill probably sell a few but the rest just wait to takeover, no urgent need for the money and any take over offer will be > the highest price paid in the prior 12 months, definitely worth holding for even if it does take a year!

Scart, absolutely no where near most knowledgeable, right now I would say the most educated in terms of Hemogenyx activities would be Pengu followed closely by a few others who have done an increadable amount of research. RE your link, I think it shows the difference between competitors and Hemogenyx, the study itself: https://apps.dtic.mil/sti/citations/AD1087498 has quotes like this: "Similar treatment in MRLlpr model of lupus did not have any effect." not knowing too much details about Lupus I believe this one treatment will potentially be benificial to a limited subset of Lupus sufferers. However I can not see any reference to the mouse model being humanised which introduces serious risks of failure at phase 1/2/3 trials. In addition the study was over a year ago and the RNS seems to be nothing more than stating the results of a year old study, personally feels like either they are going for a placing or exercise of options or something, if they were moving to next stage or had signed some sort of agreement or something fine, but they entered into an agreement in 2013...
Based on the rate of progress I see no serious competition for Hemogenyx there

I agree sentiment is low right now due to the lack of news and the negative taste left by so many failing to get in the webinar. That said I suspect that news is not far away. You should never rely on patterns however I have always suspected there would be SOMETHING every week for the next month or so about a month ago and so far that has played true.
Monday 20th July - Webinar
Monday 13th July - Name Eli Lilly
Monday 6th July - Much hyped Corporate Video
Friday 26th June - Development Agreement RE Lupus etc
Not getting my hopes up but will not be surprised to see the pattern to continue and for there to be an RNS Monday either 7am or 2pm. Previous 3 RNS/Events have been almost scripted/choreographed to "Fill the gap" between big news, and despite not having the desired effect feels too coincidental for my liking.

@Scart, I personally reported pumpkins post (Had to remove from filter to do so >.<) but I did not report yours, however hers and yours were beside each other, I believe its a manual process to delete posts and they are quite ruthless when its being done so very likely you got caught in the crossfire

If Pumpkin is on posting lies just report, it's attempted market manipulation and will get her removed, LSE pretty good at taking out the trash.

Just remember ODX are retweeting news articles instead of releasing RNS, Synairgen have already seen 500% and again have been seeking air time.
For me one of the most frustrating things about Hemo is the secrecy they operate in. You see potential elsewhere because well other companies are spending their time blowing their own trumpet.
Hemogenyx are and have been rubbish at PR, even the research note today, has Vlad mentioned it? No.
Hemo could be about to release details on a Hemo antibody ****tail + vulnerability test for Covid-19 tomorrow morning and none of us would be the wiser.
Just because others are shouting louder doesn't make them better, it's not worth the risk of getting caught out to me, but good luck!

Looks like justaman has tweeted the entire note lol! Here is the tweet chain:
https://twitter.com/justamantrading/status/1286287566141108224

This will probably help once enough people have a chance to read, this is all I am sharing from it:
Peer-group review
We have updated the peer group of ex-UK development-stage companies published in the Initiation note (August 2019). Table 1 highlights companies with operations which focus on developing treatments for blood diseases, a core area
for Hemogenyx. The average market capitalisation of the peer-group is £242m, over 7-fold higher than that of Hemogenyx (Table 1). We also compared the market capitalisation of Hemogenyx to drug developers with phase 2 assets or earlier which are listed on AIM or the LSE standard-list (Table 2). Hemogenyx’s current market capitalisation is well below that of the peer-group average of c.£97.9m. Although at a preclinical stage, Hemogenyx has a strong pipeline of assets in development,
including a COVID-19 program, as well as multiple collaboration agreements and we believe this review highlights the upside potential for the Group.
You can see in full at https://*********************/ but you need to take out a subscription first, you can join first week is free then cancel.

Not expecting any more "informative" RNS's.
Fully expect next RNS to detail a commercial Covid-19 product which will be sufficient to significantly shift the sp.
If your not in before good luck trying to buy back anywhere near your original holding!

100% agree, I am currently on 2.1m shares so considerably less but not insignificant. My shares likewise are off the table. Too much on offer with hemogenyx. I'm expecting pounds not pennies.

Shaggy, there are trades like 127 shares concidentially at 7.21 p....
Also the price paid for many of them are outside the real range offered by the MMs.
Pure and simple MM games today, When you see PEEL top of Bid and Ask its best to just roll your eyes and expect to see the SP fall until they fill the next big order.

Russell suffers from the "off chasing rainbows and wants back in before bagging syndrome" otherwise known as OCR - W - BIBS
I have grown weary of the ramping, de-ramping, bs, personal attacks and lies.
I believe in Hemogenyx so today have sold all other holdings, all my shares are now in Hemogenyx.
I have zero interest in becoming a day trader which was what was happening while I was waiting for hemo I was playing other shares with a tiny pot wasting so much time chasing profits elsewhere.
So staking my flag on Hemo.
I expect an RNS on covid or something within the next fortnight. The CDX update probably not for some time yet but by the time it lands the Covid update will mean we are at many multiples, also expecting Hu-PHEC partnership news at some point in the middle of all this + god knows what else.

My eggs are all in one basket and it feels fantastic, good luck to you all, my intention now is to visit these forums EVEN LESS than I was before and get on with my actual day job lol! :P

Absolutely Juxta I have no doubt if Hemo had paid for premium on Zoom and everyone had got in and able to see for themselves we would not have been in the red today.
The rumours, twisting of words etc has allowed negative sentiment to cause a bit of a sell off.
Reality will indeed settle in and the upward trend will continue :-)